Literature DB >> 32034780

Characterisation of endogenous Claudin-1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock-in cells.

Camille M H Clément1,2,3,4, Maika S Deffieu1,2, Cristina M Dorobantu3,4, Thomas F Baumert3,4,5, Nilda Vanesa Ayala-Nunez1,2,3,4, Yves Mély4,6, Philippe Ronde4,6, Raphael Gaudin1,2,3,4.   

Abstract

BACKGROUND INFORMATION: Claudin-1 (CLDN1) is a four-span transmembrane protein localised at cell-cell tight junctions (TJs), playing an important role in epithelial impermeability and tissue homoeostasis under physiological conditions. Moreover, CLDN1 expression is up-regulated in several cancers, and the level of CLDN1 expression has been proposed as a prognostic marker of patient survival.
RESULTS: Here, we generated and characterised a novel reporter cell line expressing endogenous fluorescent levels of CLDN-1, allowing dynamic monitoring of CLDN-1 expression levels. Specifically, a hepatocellular carcinoma Huh7.5.1 monoclonal cell line was bioengineered using CRISPR/Cas9 to endogenously express a fluorescent TagRFP-T protein fused at the N-terminus of the CLDN1 protein. These cells were proved useful to measure CLDN1 expression and distribution in live cells. However, the cells were resistant to hepatitis C virus (HCV) infection, of which CLDN1 is a viral receptor, while retaining permissiveness to VSV-G-decorated pseudoparticles. Nonetheless, the TagRFP-CLDN1+/+ cell line showed expected CLDN1 protein localisation at TJs and the cell monolayer had similar impermeability and polarisation features as its wild-type counterpart. Finally, using fluorescence recovery after photobleaching (FRAP) approaches, we measured that the majority of endogenous and overexpressed TagRFP-CLDN1 diffuses rapidly within the TJ, whereas half of the overexpressed EGFP-CLDN1 proteins were stalled at TJs.
CONCLUSIONS: The Huh7.5.1 TagRFP-CLDN1+/+ edited cell line showed physiological features comparable to that of non-edited cells, but became resistant to HCV infection. Our data also highlight the important impact of the fluorescent protein chosen for endogenous tagging. SIGNIFICANCE: Although HCV-related studies may not be achieved with these cells, our work provides a novel tool to study the cell biology of TJ-associated proteins and a potential screening strategy measuring CLDN1 expression levels.
© 2020 Société Française des Microscopies and Société de Biologie Cellulaire de France. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CLDN1; FRAP; Gene editing; HCV; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32034780      PMCID: PMC7613415          DOI: 10.1111/boc.201900085

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   3.303


  29 in total

1.  Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.

Authors:  Yi-Ying Chou; Christian Cuevas; Margot Carocci; Sarah H Stubbs; Minghe Ma; David K Cureton; Luke Chao; Frances Evesson; Kangmin He; Priscilla L Yang; Sean P Whelan; Susan R Ross; Tom Kirchhausen; Raphaël Gaudin
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  Improving the photostability of bright monomeric orange and red fluorescent proteins.

Authors:  Nathan C Shaner; Michael Z Lin; Michael R McKeown; Paul A Steinbach; Kristin L Hazelwood; Michael W Davidson; Roger Y Tsien
Journal:  Nat Methods       Date:  2008-05-04       Impact factor: 28.547

Review 3.  Non-canonical functions of claudin proteins: Beyond the regulation of cell-cell adhesions.

Authors:  Susan J Hagen
Journal:  Tissue Barriers       Date:  2017-05-19

4.  Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.

Authors:  Florian R Fritzsche; Beibei Oelrich; Manfred Johannsen; Ilka Kristiansen; Holger Moch; Klaus Jung; Glen Kristiansen
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

5.  The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state.

Authors:  Le Shen; Christopher R Weber; Jerrold R Turner
Journal:  J Cell Biol       Date:  2008-05-12       Impact factor: 10.539

6.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

Review 7.  Regulated Entry of Hepatitis C Virus into Hepatocytes.

Authors:  Zhijiang Miao; Zhenrong Xie; Jing Miao; Jieyu Ran; Yue Feng; Xueshan Xia
Journal:  Viruses       Date:  2017-05-09       Impact factor: 5.048

8.  Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin.

Authors:  M Furuse; K Fujita; T Hiiragi; K Fujimoto; S Tsukita
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

9.  Development of versatile non-homologous end joining-based knock-in module for genome editing.

Authors:  Shun Sawatsubashi; Yudai Joko; Seiji Fukumoto; Toshio Matsumoto; Shigeo S Sugano
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

10.  Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis.

Authors:  Jung-Soo Pyo; Nae Yu Kim; Won Jin Cho
Journal:  J Pathol Transl Med       Date:  2019-03-05
View more
  1 in total

Review 1.  Therapeutic Application of Genome Editing Technologies in Viral Diseases.

Authors:  Tae Hyeong Kim; Seong-Wook Lee
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.